Picture of Zimmer Biomet Holdings logo

ZBH — Zimmer Biomet Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Zimmer set for its worst day ever after cutting 2025 organic sales growth forecast

Updates

** Shares of medical device maker Zimmer Biomet Holdings ZBH.N fall 16.1% to $86.49, its lowest in over five years

** Stock set for its biggest one day pct. drop ever, if losses hold

** ZBH lowers upper end of organic sales growth forecast to 4.0% from 4.5%, maintaining lower end at 3.5%

** Co reports Q3 adj.profit of $1.90/shr vs analysts' average estimate of $1.87/shr - LSEG data

** Co reports quarterly revenue of $2 billion vs analysts' average expectation of $2.01 billion

** ZBH reports 5% organic sales growth in the third quarter

** Baird analyst says ZBH failed to "come close to touching" earlier 6% forecast

** Including session's move, stock down ~18% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))

Recent news on Zimmer Biomet Holdings

See all news